BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11563175)

  • 1. [Acute peripheral demyelinating polyneuropathy and acute renal failure after administration of FK506].
    Laham G; Vilches A; Jost L; Jost L; Nogués M
    Medicina (B Aires); 2001; 61(4):445-6. PubMed ID: 11563175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic sensorimotor polyneuropathy associated with tacrolimus immunosuppression in renal transplant patients: case reports.
    Bhagavati S; Maccabee P; Muntean E; Sumrani NB
    Transplant Proc; 2007 Dec; 39(10):3465-7. PubMed ID: 18089409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus-induced polyneuropathy after heart transplantation.
    Labate A; Morelli M; Palamara G; Pirritano D; Quattrone A
    Clin Neuropharmacol; 2010 May; 33(3):161-2. PubMed ID: 20502136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus-related polyneuropathy: case report and review of the literature.
    De Weerdt A; Claeys KG; De Jonghe P; Ysebaert D; Chapelle T; Roeyen G; Jorens PG
    Clin Neurol Neurosurg; 2008 Mar; 110(3):291-4. PubMed ID: 18055100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensorimotor neuropathy resembling CIDP in patients receiving FK506.
    Wilson JR; Conwit RA; Eidelman BH; Starzl T; Abu-Elmagd K
    Muscle Nerve; 1994 May; 17(5):528-32. PubMed ID: 7512691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demyelinating sensorimotor polyneuropathy associated with the use of sirolimus: a case report.
    Bilodeau M; Hassoun Z; Brunet D
    Transplant Proc; 2008 Jun; 40(5):1545-7. PubMed ID: 18589148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic demyelinating polyneuropathy secondary to treatment with tacrolimus].
    Rodríguez-Gómez D; Rodríguez-Rodríguez A; Pérez-Carral O; Lustres-Pérez M; Cid-Rodríguez MC
    Rev Neurol; 2008 Feb 1-15; 46(3):189-90. PubMed ID: 18297634
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe axonal polyneuropathy after a FK506 overdosage in a lung transplant recipient.
    Boukriche Y; Brugière O; Castier Y; Stocco J; Mal H; Fournier M
    Transplantation; 2001 Dec; 72(11):1849-50. PubMed ID: 11740402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetric bilateral demyelinating optic neuropathy from tacrolimus toxicity.
    Venneti S; Moss HE; Levin MH; Vagefi MR; Brozena SC; Pruitt AA; Mourelatos Z; Trojanowski JQ; Galetta SL; Balcer LJ
    J Neurol Sci; 2011 Feb; 301(1-2):112-5. PubMed ID: 21112060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe rhabdomyolysis and acute renal failure in a kidney transplant patient treated with tacrolimus and chimaeric CD25 monoclonal antibody.
    Fontana I; Ginevri F; Basile G; Beatini M; Bertocchi M; Bonifazio L; Saltalamacchia L; Ghinolfi D; Santori G; Valente R; Perfumo F; Valente U
    Transplant Proc; 2004 Apr; 36(3):711-2. PubMed ID: 15110640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus-induced encephalopathy and polyneuropathy in a renal transplant recipient.
    Wu G; Weng FL; Balaraman V
    BMJ Case Rep; 2013 Dec; 2013():. PubMed ID: 24311415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trovafloxacin-induced weakness due to a demyelinating polyneuropathy.
    Murray CK; Wortmann GW
    South Med J; 2000 May; 93(5):514-5. PubMed ID: 10832955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrotoxicity of immunosuppressive drugs.
    Bennett WM; Burdmann E; Andoh T; Elzinga L; Franceschini N
    Miner Electrolyte Metab; 1994; 20(4):214-20. PubMed ID: 7531274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late-onset tacrolimus-associated cerebellar atrophia in a heart transplant recipient.
    Kaczmarek I; Schmauss D; Sodian R; Beiras-Fernandez A; Oberhoffer M; Daebritz S; Schoenberg SO; Reichart B
    J Heart Lung Transplant; 2007 Jan; 26(1):89-92. PubMed ID: 17234523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive neurological disease induced by tacrolimus in a renal transplant recipient: case presentation.
    Chegounchi M; Hanna MG; Neild GH
    BMC Nephrol; 2006 Mar; 7():7. PubMed ID: 16573841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of tacrolimus in postoperative treatment of patients with renal transplantation for diabetic end-stage renal disease].
    Yu LX; Shan HT; Fu SJ; Du CF; Ma JJ; Xu J; Deng WF; Wang YB
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1146-8. PubMed ID: 14625173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute polyneuropathy after high dose cytosine arabinoside in patients with leukemia.
    Openshaw H; Slatkin NE; Stein AS; Hinton DR; Forman SJ
    Cancer; 1996 Nov; 78(9):1899-905. PubMed ID: 8909309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of tacrolimus (FK506)-induced pancreatitis and fatality 2 years postcadaveric renal transplant.
    Ogunseinde BA; Wimmers E; Washington B; Iyob M; Cropper T; Callender CO
    Transplantation; 2003 Jul; 76(2):448. PubMed ID: 12883222
    [No Abstract]   [Full Text] [Related]  

  • 19. Tacrolimus-associated myositis: a case report in a renal transplant patient.
    Orlandi V; Campieri C; Mosconi G; D'Arcangelo GL; Feliciangeli G; Scolari MP; Stefoni S
    Transplant Proc; 2004 Apr; 36(3):708-10. PubMed ID: 15110639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fever of unknown origin in renal transplant patients with tacrolimus.
    Hochegger K; Rudnicki M; Auinger M; Mark W; Margreiter R; Mayer G; Rosenkranz AR
    Clin Transplant; 2009; 23(4):575-9. PubMed ID: 19191804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.